Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Depreciation and Depletion (2016 - 2017)

Avalo Therapeutics filings provide 4 years of Depreciation and Depletion readings, the most recent being $4906.0 for Q4 2017.

  • On a quarterly basis, Depreciation and Depletion fell 23.2% to $4906.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $21956.0, a 18.25% decrease, with the full-year FY2025 number at $300000.0, up 50.0% from a year prior.
  • Depreciation and Depletion hit $4906.0 in Q4 2017 for Avalo Therapeutics, down from $5361.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $7881.0 in Q4 2014 to a low of $4906.0 in Q4 2017.
  • Median Depreciation and Depletion over the past 4 years was $6148.0 (2015), compared with a mean of $6169.3.
  • Biggest five-year swings in Depreciation and Depletion: grew 22.99% in 2016 and later dropped 23.98% in 2017.
  • Avalo Therapeutics' Depreciation and Depletion stood at $7881.0 in 2014, then fell by 21.99% to $6148.0 in 2015, then rose by 3.9% to $6388.0 in 2016, then dropped by 23.2% to $4906.0 in 2017.
  • The last three reported values for Depreciation and Depletion were $4906.0 (Q4 2017), $5361.0 (Q3 2017), and $5859.0 (Q2 2017) per Business Quant data.